IART Q3 2021 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$387M+4.5% YoY

Gross Profit

$242M62.7% margin

Operating Income

$56M14.6% margin

Net Income

$43M11.2% margin

EPS (Diluted)

$0.51

QoQ Revenue Growth

-0.8%

Cash Flow

Operating Cash Flow

$83M

Free Cash Flow

$75M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3.8B

Total Liabilities

$2.1B

Stockholders' Equity

$1.6B

Cash & Equivalents

$470M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$387M	$370M	+4.5%
Gross Profit	$242M	$235M	+3.0%
Operating Income	$56M	$58M	-1.9%
Net Income	$43M	$32M	+33.7%

Revenue Segments

Codman Specialty Surgical

$256M66%

Tissue Technologies

$130M34%

Geographic Segments

UNITED STATES

$276M71%

Europe

$46M12%

Asia Pacific

$45M12%

Rest Of World

$20M5%